Physician

May Azem, MD

According to 2025 Medicare claims, May Azem, MD (NPI: 1407049133) practices rheumatology in the Cleveland, OH market, with the plurality of this provider's patient population coming from Lake, OH. This provider's primary affiliated billing organization is MAY AZEM MD INC (NPI: 1427322296; TIN: 454522761) and primary practice location at 44077-9406.

Azem's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 386 traditional Medicare patients, billed 174,695 HCPCS/CPT codes, and received $2,239,242 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 4,495 prescription claims across 542 beneficiaries totaling $4,515,739 in drug costs, led by Enbrel Sureclick (Etanercept). Open Payments data shows 198 records totaling $5,050. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $38,300 to $2,239,242. Similarly, Part D prescription costs have risen steadily, from $2,348,060 to $4,515,739. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	146	1,189	$38,300
2016	167	1,392	$40,057
2017	165	1,193	$39,316
2018	222	1,013	$34,876
2019	337	103,270	$2,022,415
2020	303	89,227	$1,754,364
2021	324	87,291	$1,667,207
2022	360	119,734	$1,797,875
2023	360	131,751	$1,846,427
2024	386	174,695	$2,239,242

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	274	2,581	$2,348,060
2016	343	2,662	$3,143,193
2017	263	2,462	$3,072,359
2018	310	2,229	$2,857,744
2019	439	3,466	$1,435,389
2020	401	4,019	$2,260,004
2021	416	4,141	$3,121,087
2022	482	4,457	$4,084,231
2023	511	4,652	$4,612,362
2024	542	4,495	$4,515,739

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	134	222	$126
96413	Administration of chemotherapy into vein, 1 hour or less	119	754	$93
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	315	688	$88
96401	Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle	65	274	$52
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	180	332	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel Sureclick	Etanercept	101	4,044	$1,069,798
Xeljanz Xr	Tofacitinib Citrate	96	3,120	$613,239
Cosentyx Unoready Pen	Secukinumab	30	1,120	$392,350
Cosentyx Sensoready (2 Pens)	Secukinumab	50	1,456	$382,686
Cimzia (2 Pack)	Certolizumab Pegol	32	1,200	$262,529

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	198	$5,050	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for May Azem, MD?

Tedicare shows public-source Medicare data for May Azem, MD (NPI 1407049133), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does May Azem, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to May Azem, MD?

May Azem, MD is linked to MAY AZEM MD INC (billing NPI 1427322296) in the available physician profile data.

Does May Azem, MD have Open Payments data?

May Azem, MD has 198 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.